Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „sections“
Suchtreffer
Begriffe & Kennungen
Docetaxel Kabi · 4.8 · 151 interruption or discontinuation of docetaxel treatment were reported (see sections 4.2 and 4.4). Severe na
Eintrag öffnenDocetaxel Kabi · 4.8 · The development of severe peripheral neurotoxicity requires a reduction of dose (see sections 4.2 and 4.4). Mi
Eintrag öffnenDocetaxel Kabi · 4.8 · The development of severe peripheral neurotoxicity requires a reduction of dose (see sections 4.2 and 4.4). Mi
Eintrag öffnenDocetaxel Kabi · 4.8 · The development of severe peripheral neurotoxicity requires a reduction of dose (see sections 4.2 and 4.4). Mi
Eintrag öffnenDocetaxel Kabi · 4.8 · The development of severe peripheral neurotoxicity requires a reduction of dose (see sections 4.2 and 4.4). Mi
Eintrag öffnenDocetaxel Kabi · 4.8 · The development of severe peripheral neurotoxicity requires a reduction of dose (see sections 4.2 and 4.4). Mi
Eintrag öffnenDynastat · 4.3 · 19 The third trimester of pregnancy and breast-feeding (see sections 4.6 and 5.3).
Eintrag öffnenDynastat · 4.3 · 3 The third trimester of pregnancy and breast-feeding (see sections 4.6 and 5.3).
Eintrag öffnenDynastat · 4.3 · Treatment of post-operative pain following coronary artery bypass graft (CABG) surgery (see sections 4.8 and 5
Eintrag öffnenDynastat · 4.3 · Treatment of post-operative pain following coronary artery bypass graft (CABG) surgery (see sections 4.8 and 5
Eintrag öffnenEfficib · 4.3 · - hypersensitivity to the active substances or to any of the excipients listed in section 6.1 (see sections 4.
Eintrag öffnenEmtriva · 4.8 · 20 adjustment is required in all patients with creatinine clearance < 30 mL/min (see sections 4.2, 4.4 and 5.2
Eintrag öffnenEndoskopische Mukosaresektion
Eintrag öffnenEurartesim · 4.5 · Food interaction Absorption of piperaquine is increased in the presence of fatty food (see sections 4.4 and 5.
Eintrag öffnenEurartesim · 4.5 · Food interaction Absorption of piperaquine is increased in the presence of fatty food (see sections 4.4 and 5.
Eintrag öffnenEviplera · 4.8 · Renal impairment As Eviplera may cause renal damage, monitoring of renal function is recommended (see sections
Eintrag öffnenEx utero Intrapartum Treatment Procedures
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Hypersensitivity to the active substance (human immunoglobulins) or to any of the excipients (see sections 4.4
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Hypersensitivity to the active substance (human immunoglobulins) or to any of the excipients (see sections 4.4
Eintrag öffnenGazyvaro · 4.8 · The incidences presented in the following sections if referring to iNHL are the highest incidence of that ADR
Eintrag öffnen